We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
ICL Group Ltd | NYSE:ICL | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.83 | 4.89 | 4.79 | 4.85 | 725,610 | 01:00:00 |
Company Symbol Percent Current Offer IPO Date* ReWalk Robotics Ltd. RWLK 148% $29.80 $12.00 12-Sep-14 Mobileye NV MBLY 104% $50.95 $25.00 1-Aug-14 CyberArk Softward Ltd. CYBR 65% $26.47 $16.00 24-Sep-14 T2 Biosystems Inc. TTOO 61% $17.75 $11.00 7-Aug-14 Otonomy Inc. OTIC 50% $24.05 $16.00 13-Aug-14 Alibaba Group Holding Ltd. BABA 32% $89.75 $68.00 19-Sep-14 ProQ Therapeutics BV PRQR 27% $16.55 $13.00 18-Sep-14 Ryerson Holding Corp. RYI 26% $13.87 $11.00 8-Aug-14 iDreamSky Technology Ltd. DSKY 26% $18.86 $15.00 7-Aug-14 Hoegh LNG Partners LP HMLP 16% $23.28 $20.00 7-Aug-14 Green Bancorp Inc. GNBC 13% $17.02 $15.00 8-Aug-14 C1 Financial Inc. BNK 8% $18.42 $17.00 14-Aug-14 Citizens Financial Group Inc. CFG 7% $22.95 $21.50 24-Sep-14 Tokai Pharmaceuticals Inc. TKAI 6% $15.83 $15.00 17-Sep-14 Smart & Final Stores Inc. SFS 4% $12.53 $12.00 24-Sep-14 Independence Contract Drilling Inc. ICD 3% $11.32 $11.00 8-Aug-14 FCB Financial Holdings Inc. FCB 2% $22.39 $22.00 1-Aug-14 Israel Chemicals Ltd. ICL 1% $7.10 $7.00 24-Sep-14 Auris Medical Holding AG EARS -2% $5.91 $6.00 6-Aug-14 Civitas Solutions Inc. CIVI -5% $16.20 $17.00 17-Sep-14 Vitae Pharmaceuticals Inc. VTAE -6% $7.50 $8.00 24-Sep-14 Foamix Pharma Ltd. FOMX -7% $5.60 $6.00 18-Sep-14 Loxo Oncology Inc. LOXO -8% $11.96 $13.00 1-Aug-14 Medley Management Inc. MDLY -10% $16.20 $18.00 24-Sep-14 Affimed Therapeutics BV AFMD -10% $6.29 $7.00 12-Sep-14 *Date represents first day of trading
1 Year ICL Chart |
1 Month ICL Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions